TUCSON, Ariz. , Oct. 31, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the third quarter ended September 30, 2019 after the market close on…
Join HTG at the 5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference
TUCSON, Ariz. , Oct. 22, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) , a diagnostic company whose mission is to advance precision medicine, today announced that it will host a Key Opinion Leader (KOL) luncheon at 12:00 pm ET on Tuesday, October 29 th in New York City ….
Join HTG at the 4th Annual Companion Diagnostics Forum October 29 - 30 in Princeton, NJ!
TUCSON, Ariz. , Oct. 15, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it will begin taking orders for its new 2,002-gene HTG EdgeSeq Autoimmune Panel, which is expected to be…
TUCSON, Ariz. , Oct. 10, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today provided an update regarding its ongoing efforts related to the development, manufacture and commercialization of…
Reliable Gene Expression Profiling from Clinical Formalin-Fixed, Paraffin-Embedded (FFPE) Specimens Using the HTG EdgeSeq Platform
TUCSON, Ariz. , Sept. 30, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that John Lubniewski , President and CEO, will present a corporate overview at the Cantor 2019 Global…
TUCSON, Ariz. –(BUSINESS WIRE)–Sep. 20, 2019– HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced the pricing of an underwritten public offering of 25,476,989 shares of its common stock at a price to the…
Product and product-related services revenue increased by 119% and 89%, respectively, compared to the three and six-month periods in the prior year Call scheduled for today, August 6 , at 4:30pm ET TUCSON, Ariz. , Aug. 06, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc….
TUCSON, Ariz. , July 25, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that John Lubniewski , President and CEO, will present a corporate overview at the Canaccord Genuity 39 th…
TUCSON, Ariz. , July 24, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2019 after the market close on…
Page last updated March 20, 2023